公开(公告)号：EP3110810A1

公开(公告)日：2017-01-04

申请号：EP15713244.0

申请日：2015-02-27

申请人： Teijin Pharma Limited ,  Amgen Inc.

发明人： BECK, Hilary Plake ,  BOOKER, Shon Keith ,  BREGMAN, Howard ,  CEE, Victor J. ,  CHAKKA, Nagasree ,  CUSHING, Timothy D. ,  EPSTEIN, Oleg ,  FOX, Brian M. ,  GEUNS-MEYER, Stephanie ,  HAO, Xiaolin ,  HIBIYA, Kenta ,  HIRATA, Jun ,  HUA, Zihao ,  HUMAN, Jason ,  KAKUDA, Shinji ,  LOPEZ, Patricia ,  NAKAJIMA, Ryota ,  OKADA, Kazuhisa ,  OLSON, Steven H. ,  OONO, Hiroyuki ,  PENNINGTON, Lewis D. ,  SASAKI, Kosuke ,  SHIMADA, Keiko ,  SHIN, Youngsook ,  WHITE, Ryan D. ,  WURZ, Ryan P. ,  YI, Shuyan ,  ZHENG, Xiao Mei

IPC分类号： C07D403/12 ,  C07D401/14 ,  C07D405/14 ,  C07D231/14 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D417/14 ,  C07D493/08 ,  A61K31/4155 ,  A61P29/00

CPC分类号： C07D231/14 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D413/12 ,  C07D417/14 ,  C07D493/08

摘要： The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

摘要翻译： 本发明涉及具有抑制RORγ活性功能的新型化合物。 本发明还涉及包含该化合物的药物组合物，该化合物在治疗或预防自身免疫性疾病，炎性疾病，代谢性疾病或癌症疾病中的用途。

公开(公告)号：EP3110810B1

公开(公告)日：2018-05-02

申请号：EP15713244.0

申请日：2015-02-27

申请人： Teijin Pharma Limited

发明人： BECK, Hilary Plake ,  BOOKER, Shon Keith ,  BREGMAN, Howard ,  CEE, Victor J. ,  CHAKKA, Nagasree ,  CUSHING, Timothy D. ,  EPSTEIN, Oleg ,  FOX, Brian M. ,  GEUNS-MEYER, Stephanie ,  HAO, Xiaolin ,  HIBIYA, Kenta ,  HIRATA, Jun ,  HUA, Zihao ,  HUMAN, Jason ,  KAKUDA, Shinji ,  LOPEZ, Patricia ,  NAKAJIMA, Ryota ,  OKADA, Kazuhisa ,  OLSON, Steven H. ,  OONO, Hiroyuki ,  PENNINGTON, Lewis D. ,  SASAKI, Kosuke ,  SHIMADA, Keiko ,  SHIN, Youngsook ,  WHITE, Ryan D. ,  WURZ, Ryan P. ,  YI, Shuyan ,  ZHENG, Xiao Mei

IPC分类号： C07D403/12 ,  C07D401/14 ,  C07D405/14 ,  C07D231/14 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D417/14 ,  C07D493/08 ,  A61K31/4155 ,  A61P29/00

CPC分类号： C07D231/14 ,  C07D401/12 ,  C07D401/14 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D409/12 ,  C07D413/12 ,  C07D417/14 ,  C07D493/08

摘要： The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

公开(公告)号：EP1358184A1

公开(公告)日：2003-11-05

申请号：EP02717325.1

申请日：2002-01-11

申请人： Amgen Inc.

发明人： CHEN, Guoqing ,  ADAMS, Jeffrey ,  BEMIS, Jean ,  BOOKER, Shon ,  CAI, Guolin ,  CROGHAN, Michael ,  DIPIETRO, Lucian ,  DOMINGUEZ, Celia ,  ELBAUM, Daniel ,  GERMAIN, Julie ,  GEUNS-MEYER, Stephanie ,  HANDLEY, Michael ,  HUANG, Qi ,  KIM, Joseph, L. ,  KIM, Tae-Seong ,  KISELYOV, Alexander ,  OUYANG, Xiaohu ,  PATEL, Vinod, F. ,  SMITH, Leon, M. ,  STEC, Markian ,  TASKER, Andrew ,  XI, Ning ,  XU, Shimin ,  YUAN, Chester Chenguang

IPC分类号： C07D409/12 ,  C07D409/14 ,  C07D213/82 ,  C07D401/12 ,  C07D401/14 ,  C07D409/04 ,  C07D413/14 ,  C07D417/14 ,  C07D405/14 ,  C07D405/12

CPC分类号： C07D213/82 ,  A61K31/443 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/4545 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/506 ,  A61K31/5377 ,  A61K31/538 ,  C07D401/12 ,  C07D401/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/00 ,  C07D409/04 ,  C07D409/12 ,  C07D409/14 ,  C07D413/14 ,  C07D417/14 ,  C07D471/04

摘要： Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

公开(公告)号：EP1358184B1

公开(公告)日：2007-05-02

申请号：EP02717325.1

申请日：2002-01-11

申请人： AMGEN INC.

发明人： CHEN, Guoqing ,  ADAMS, Jeffrey ,  BEMIS, Jean ,  BOOKER, Shon ,  CAI, Guolin ,  CROGHAN, Michael ,  DIPIETRO, Lucian ,  DOMINGUEZ, Celia ,  ELBAUM, Daniel ,  GERMAIN, Julie ,  GEUNS-MEYER, Stephanie ,  HANDLEY, Michael ,  HUANG, Qi ,  KIM, Joseph, L. ,  KIM, Tae-Seong ,  KISELYOV, Alexander ,  OUYANG, Xiaohu ,  PATEL, Vinod, F. ,  SMITH, Leon, M. ,  STEC, Markian ,  TASKER, Andrew ,  XI, Ning ,  XU, Shimin ,  YUAN, Chester Chenguang

IPC分类号： C07D401/14

CPC分类号： C07D213/82 ,  A61K31/443 ,  A61K31/4439 ,  A61K31/444 ,  A61K31/4545 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/496 ,  A61K31/506 ,  A61K31/5377 ,  A61K31/538 ,  C07D401/12 ,  C07D401/14 ,  C07D405/12 ,  C07D405/14 ,  C07D409/00 ,  C07D409/04 ,  C07D409/12 ,  C07D409/14 ,  C07D413/14 ,  C07D417/14 ,  C07D471/04

摘要： Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.